Skip to main content

Ru486 Drug

Volume 168: debated on Thursday 8 March 1990

The text on this page has been created from Hansard archive content, it may contain typographical errors.

To ask the Secretary of State for Health whether any application has yet been received for a product licence in connection with the abortifacient drug RU486.

For reasons of commercial confidentiality, it is not usual practice to disclose information about whether or not an application for a product licence has been received or to give information about the progress of any such application.